Brain cancer imaging study aims to predict treatment success

NCT ID NCT03297125

Ongoing Knowledge-focused Sponsor: Medical College of Wisconsin Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This study looks at whether advanced MRI scans can predict how well Optune therapy works in people with newly diagnosed glioblastoma, a type of brain cancer. Researchers will compare standard and advanced MRI in 60 participants to see which better forecasts survival at six months and one year. The goal is to improve treatment planning by identifying who is most likely to benefit from Optune.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors use MRI scans to predict which patients will benefit from Optune therapy, personalizing treatment for glioblastoma.
What could go wrong: This is an early-phase observational study, not a treatment trial. It may not lead to changes in clinical practice, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glioblastoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLIOBLASTOMA

Contacts and locations

Locations

Froedtert Hospital & Medical College of Wisconsin

Milwaukee, Wisconsin, 53202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.